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Abstract
Background: Indigenous Australians have poorer cancer outcomes in terms of incidence mortality and survival
compared with non-Indigenous Australians. The factors contributing to this disparity are complex. Identifying and
addressing the psychosocial factors and support needs of Indigenous cancer patients may help reduce this
disparity. The Supportive Care Needs Assessment Tool for Indigenous People (SCNAT-IP) is a validated 26-item
questionnaire developed to assess their unmet supportive care needs. This qualitative study reports on patient and
clinician attitudes towards feasibility and acceptability of SCNAT-IP in routine care.
Methods: Forty-four in-depth semi-structured interviews were conducted with 10 clinical staff and 34 Indigenous
cancer patients with heterogeneous tumours. Participants were recruited from four geographically diverse Australian
cancer clinics. Transcripts were imported into qualitative analysis software (NVivo 10 Software), coded and thematic
analysis performed.
Results: Indigenous patients (mean age 54.4 years) found the SCNAT-IP beneficial and easy to understand and they
felt valued and heard. Clinical staff reported multiple benefits of using the SCNAT-IP. They particularly appreciated its
comprehensive and systematic nature as well as the associated opportunities for early intervention. Some staff described
improvements in team communication, while both staff and patients reported that new referrals to support services
were directly triggered by completion of the SCNAT-IP. There were also inter-cultural benefits, with a positive and
bi-directional exchange of information and cultural knowledge reported when using the SCNAT-IP. Although staff
identified some potential barriers to using the SCNAT-IP, including the time required, the response format and
comprehension difficulties amongst some participants with low English fluency, these were outweighed by the
benefits. Some areas for scaled improvement were also identified by staff.
Conclusions: Staff and patients found the SCNAT-IP to be an acceptable tool and supported universal screening for
Indigenous cancer patients. The SCNAT-IP has the potential to help reduce the inequalities in cancer care experienced
by Indigenous Australians by identifying and subsequently addressing their unmet support needs. Further research is
needed to explore the validity of the SCNAT-IP for Indigenous people from other nations.
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Background
Indigenous people comprise about five percent of the
world’s population [1]. Inequalities with regard to Indigen-
ous cancer outcomes have been documented in Australia,
New Zealand, Latin America, the Caribbean and the
United States [2–6]. In Australia, cancer remains the sec-
ond leading cause of death among Indigenous people [7].
The patterns of cancer care between Indigenous and non-
Indigenous patients differ, with Indigenous patients often
receiving less optimal treatment [8–10]. Indigenous
Australians’ engagement in cancer care is lower at all
stages of the cancer continuum including screening,
early presentation at diagnosis, continuity of care, and
compliance with treatment [11–14]. This has resulted
in significantly poorer cancer outcomes in terms of
incidence, mortality and survival.
Aspects of the broader social environment may influ-
ence the way individuals, families and communities en-
gage with health care and manage their own health [15].
Understanding Indigenous people’s experience of cancer
must take into account the social determinants of health
and the cultural context of people’s lives, and these
should be reflected in service delivery models and in the
delivery of cancer care [16]. Indigenous Australians' col-
lective experience of racism, discrimination, alienation
and marginalisation has led to widespread distrust of the
health care systems including cancer care and treatment
services [15, 17, 18].
It has been widely recognised that there is a lack of
culturally appropriate health care services to engage In-
digenous Australians [19–22]. Differences in communi-
cation, information needs and language have inhibited
Indigenous people’s engagement with cancer care [19,
23–25]. This issue is highlighted in a study that was con-
ducted with cancer care professionals, where participants
reported doubts about their ability to adequately commu-
nicate important information to Indigenous patients [17].
Effective communication between patients and their physi-
cians is essential to ensure optimal patient outcomes [26].
Furthermore, several studies have highlighted cultural
differences in the way many Indigenous people perceive
cancer (a highly feared disease that equates to death), re-
ceive and process information about their cancer diag-
nosis and treatment, and cope with illness [11, 27–29].
Research into the psychosocial factors and specific sup-
portive care needs of Indigenous people with cancer is
imperative.
Improved supportive care for Indigenous cancer pa-
tients is an important strategy which may ultimately help
narrow current disparities in cancer outcomes.
Many questionnaires have been developed to assess
the unmet needs of cancer patients [30]. Some have
been developed for specific cancers or settings, but little
attention has been given to assessing the appropriateness
of existing tools for minorities or developing tools that
assess the culture-specific needs of different ethnic
groups [30]. In Australia, Indigenous cancer patients
share many supportive care needs with non-Indigenous
cancer patients, but they have additional culture-specific
needs that are not addressed by existing measures [31].
To address this gap, a Supportive Cancer Needs Assess-
ment Tool for Indigenous People (SCNAT-IP) has been
developed [31, 32].
The broader clinical implementation feasibility study
has been reported elsewhere [33]. While integrating
qualitative and quantitative data can complement and
deepen the interpretation of findings, we justify presen-
tating the qualitative data separately on the basis of: (a)
the paucity of research involving Indigenous cancer pa-
tients and in particular studies which explore unmet
support needs; (b) the richness of the qualitative data;
and (c) being able to illustrate the range and depth of
participants needs and concerns in their own words ra-
ther than by a summary of themes. This study describes
patient and staff attitudes towards the acceptability and
feasibility of the SCNAT-IP in routine care. Additionally,
this study aimed to identify refinements needed to pre-
pare the SCNAT-IP for use in clinical settings.
Methods
Ethical considerations, Study sites and participant
eligibility criteria
Ethical clearance was obtained from the following Hu-
man Research Ethics Committees: Northern Territory
(NT) Department of Health & Families and the Menzies
School of Health Research (HREC13/1994); Peter Mac-
Callum Cancer Centre (HREC/13/45); Greater Western
Human Research Ethics Committee (HRECI131G-
WAHSI39) and the Aboriginal Health and Medical Re-
search Council of New South Wales (NSW; HREC/946/
12). The content of this manuscript was subject to ap-
proval by the Aboriginal Health and Medical Research
Council of NSW in accordance with the standard condi-
tions of their ethical approval.
Participants were recruited from one of four participat-
ing sites: a tertiary cancer centre in the NT servicing outer
regional and remote areas; a large metropolitan tertiary
cancer centre in Victoria; and two regional cancer clinics
in NSW. These four services represented a diversity of
geographical locations, service models and Indigenous
communities. All participating sites had a relatively high
proportion of Indigenous patients, and/or dedicated Indi-
genous hospital liaison staff or an interest in improving
service delivery for Indigenous patients.
Eligible patients were over 18 years of age, of
Australian Indigenous background, were diagnosed
five years ago or less with malignant disease, and were ei-
ther receiving or about to receive treatment (including
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surgery, chemotherapy, radiotherapy, stem cell transplant,
endocrine therapy or immunotherapy) or were in follow-
up care. Recruitment was conducted over a three to five
month period (November 2013-March 2014). Interviews
were verbally administered, and health care interpreters
were available upon request by staff at the NT site where
many Indigenous people speak a language other than Eng-
lish. Those unable to give informed consent due to cogni-
tive and/or physical impairments were excluded. Eligible
cancer nurses, oncology social workers, Indigenous health
workers (IHWs) or other allied health professionals were
identified by their manager as providing supportive care
to cancer patients and invited to participate in the training
for this study.
Procedure
After written informed consent was obtained, all health
professionals involved in this study completed a specific-
ally developed three hour training session, which in-
cluded background information, clinical use of the
SCNAT-IP and the research protocol. Following training,
all staff at participating sites were asked to identify and
refer all eligible Indigenous cancer patients to trained
clinical staff for needs assessment. Trained clinical staff
(oncology social workers, nurses and clinical trials coor-
dinators) introduced the study to patients, gained written
informed consent and conducted needs assessment at rou-
tine patient clinic visits. Where moderate to high levels of
needs were identified (i.e. scores of four or five on any
SCNAT-IP item), these were discussed with patients and
they were offered assistance in accordance with usual care.
Following needs assessment, patients, along with a
trained clinical staff member, completed quantitative
questionnaire items exploring the acceptability and feasi-
bility of the SCNAT-IP; these results are reported else-
where [33]. Immediately following this, a trained IHW (or
a trained clinical staff member if the IHW was unavail-
able), conducted an audiotaped face-to-face or telephone
interview which aimed to gather qualitative information
about patient attitudes towards unmet needs screening.
Telephone interviews were offered for pragmatic reasons
(e.g. when patients' transport was scheduled immediately
after the completion of their appointment).
At the conclusion of the data collection period, trained
clinical staff completed a brief telephone interview with
a member of the research team (BT). Recruitment con-
tinued until no new themes emerged from the data. Pa-
tients' clinical details were collected by clinical staff from
medical records.
Measures
Patient clinical and demographic characteristics
Socio-demographic variables were collected by interview.
Clinical details including cancer type, disease status,
treatment phase, and cancer treatments were collected
from medical records.
Supportive care needs assessment tool for indigenous
people (SCNAT-IP)
The SCNAT-IP is a 27-item (including one open-ended
question) verbally-administered unmet needs measure. It
consists of four domains: physical and psychological
needs (11 items); hospital care needs (four items); infor-
mation and communication needs (six items) and prac-
tical and cultural needs (five items). Items included but
were not limited to the following: ‘feeling tired, feeling
down or sad’ and ‘keeping you strong in your spirit’
(physical and psychological needs domain); ‘having hos-
pital staff show sensitivity to and respecting your feelings
and emotional needs’; and ‘being treated like a person
not just another case or number’ (hospital care needs
domain); ‘being shown or given information (e.g., writ-
ten, diagrams) about how to manage your illness and
side effects at home’ (information and communication
needs domain); and ‘finding a place to stay while receiv-
ing treatment and money worries’ (practical and cultural
needs domain) [32].
For each item respondents report a yes/no response. If a
need was present in the past month they were asked to
choose the degree to which they required help on a scale
ranging from ‘satisfied because my needs were met’
(scored as one) to ‘a lot more help needed’ (scored as five).
To assist with comprehension, participants were given a
hard copy of response categories and the interviewer re-
corded participants' responses [31]. The SCNAT-IP ac-
commodates the language, customs and culture-specific
needs of Indigenous Australians and excludes items which
are culturally-inappropriate in the screening context (e.g.
sexual needs). The tool also includes culture-specific items
such as having an Indigenous person to talk to and sup-
port you, someone who understands your culture [31]. It
takes approximately 15-20 min to complete and has been
demonstrated to have good construct and face validity as
well as internal consistency in a large sample of Indigen-
ous cancer patients [31, 32].
Patient acceptability interview
A brief semi-structured face-to-face interview was used
to qualitatively explore the participants’ attitudes with
regards to needs assessment. Interview questions explored
perceived benefits of needs assessment, acceptability, ap-
propriateness of content and timing, and attitudes towards
universal screening for Indigenous patients.
Health professional characteristics
Items were developed to assess demographic characteris-
tics, role, education, employment location, years of experi-
ence and prior supportive care needs assessment training.
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Health professional acceptability and feasibility telephone
interview
Six semi-structured interview questions assessed per-
ceived benefits, barriers to use, impact on workload, im-
pact on team communication/referral pathways, and
recommendations for changes to the SCNAT-IP.
Data analysis
Demographic data were analysed using descriptive statis-
tics. Interview audio recordings were transcribed verbatim.
Data analysis was performed using QSR International's
NVivo 10 Software [34]. Thematic analysis was performed
in six phases including: familiarisation with data; gener-
ation of initial codes; searching for themes among codes;
reviewing themes; defining and naming themes; and syn-
thesising the final results [35]. The generation of coding
was conducted by one member of the research team (BT),
and verified by a second member of the research team
(GG) who double-coded 10 % of transcripts to ensure
inter-coder agreement. Where discrepancies arose in cod-
ing or definition of themes, these were resolved through
discussion until consensus was reached.
Results
Response rate and patient characteristics
Of the 89 potentially eligible participants, 45 (51 %) were
invited to participate in the study. Thirty-six (80 %) of
these agreed to be interviewed and two participants were
further excluded leaving a final study sample of 34
(76 %) (Fig. 1).
Participants were aged 34-76 years (mean=54.4,
SD=11.0) and the majority were female (68 %), partnered
(53 %), living outside metropolitan cities (89 %) and had
not completed high-school (60 %). Breast cancer was the
most common cancer type (35 %); 31 % had local disease
and 47 % were receiving active treatment (Table 1).
Health professional participants and response rate
The SCNAT-IP study training session included 22 health
professionals with an average age of 42 years (range 25-62,
SD=11.4) and a diverse set of professional back-
grounds including social workers (n = 8), nurse care
coordinators (n = 4), radiation therapist (n = 1), clinical
trial coordinator (n = 1), IHWs (n = 5) and service
managers (n = 3). Ten of the 22 session participants
conducted needs assessments using the SCNAT-IP.
All were non-Indigenous females; six were oncology
social workers; nine had post-graduate qualifications;
and six had no previous needs assessment training.
Half had six years or more experience in cancer care
and worked in regional locations. The other 12 health
professionals conducted follow-up interviews only or
supported the study as service managers.
Patient interviews
The results are reported for the combined group be-
cause participant views were common across genders,
89 Indigenous cancer patients 
identified by health professional staff 
Inclusion Criteria:
- Australian Indigenous person
- Adult (≥ 18 years)
- Cancer diagnosis 5 years or less
- Attending hospital for their cancer
- Able to understand English
- Cognitive and physical ability to 
provide informed consent
Initial exclusions:
- Not contactable, e.g. missed 
appointment, early discharge, staff 
workload and leave (n=44, 49%)
36 (80%) of those approached were interviewed
Final study participants n=34
Further exclusions:
-Lost to follow up or audio recording was of 
poor quality (n=2; 6%)
45 (51%) approached to be interviewed
Additional exclusions:
- Ineligible, not Indigenous or were physically 
and/or mentally unwell (n=5, 11%)
- Declined to participate (n=4, 11%)
Fig. 1 Flow of patient participant recruitment
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age groups, cancer types, cancer centres and mode of
interview. Insufficient patients were interviewed by
phone to formally explore whether the mode of inter-
view influenced the results obtained.
Feasibility and acceptability
The majority of participants liked being asked about
their needs, did not mind taking the time to answer
questions and generally found the process very helpful.
Some said they liked the process of needs assessment
because it made them feel heard and it linked them to
services. As one participant who lived in a regional area
said:
“This is just a god send to me because now I know I’m
going to get some help because it’s always been a real
battle for me.”
(Female, 50 years)
Another female participant reported feeling “empow-
ered” by the process of needs assessment. Several partici-
pants appreciated that health professionals were interested
in finding out about their needs and that they showed an
interest particularly in the needs of Indigenous cancer
patients.
“It’s made me feel good that someone’s showing
interest, you know. That there's people out there who
Table 1 Demographic and clinical characteristics of the patient
sample (n = 34)
n %a
Sex
Male 11 32
Female 23 68
Remoteness of residenceb
Major city 4 12
Regional 24 71
Remote 6 18
Marital status
Single 10 29
Married/De Facto 18 53
Widowed/Separated/divorced 6 18
Main language spoken at home
English 19 56
Indigenous language 15 44
Education level
Junior High School or below 21 62
Senior High School 5 15
Diploma/Trade/University degree 8 12
Cancer Type
Breast 12 35
Colorectal 6 18
Head & neck 6 18
Lung 3 9
Gynaecological 2 6
NHLc 1 3
Haematological 1 3
Other 3 9
Cancer Stage
Local disease 11 32
Regional spread 5 15
Distal metastases 12 35
Not applicable 3 9
Not known 3 9
Treatment status
Newly diagnosed 4 12
Receiving treatmentd 16 47
Follow-up care 14 41
Treatment type
Surgery
Completed 22 65
Planned 3 9
No/Not applicable 9 26
Table 1 Demographic and clinical characteristics of the patient
sample (n = 34) (Continued)
Chemotherapy
Yes 22 65
No 12 35
Radiotherapy
Yes 21 62
No 13 38
Other cancer treatmentsf
Yes 13 38
No 21 62
Comorbidities
Diabetes 8 24
Cardiovascular 9 27
Respiratory 9 27
Othere 15 44
Notes: aMay not sum to 100 % due to rounding; bclassified according to
Accessibility/Remoteness Criteria of Australia (ARIA) for further information see
AIHW [15]. cNon-Hodgkins Lymphoma; dincludes all active hospital-based
cancer treatments; eincludes: Substance Abuse, Psychiatric, Renal disease,
Neurological and Gastrointestinal disorders; fIncludes: hormonal therapy,
brachytherapy, microwave ablation
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are trying to improve things, not only for cancer
patients but for Indigenous people.”
(Male, 45 years)
Only one participant reported negative feelings about
the SCNAT-IP, saying she felt “uptight” being asked
about her unmet needs but later clarified “cause [I] told
her [health professional] a few things that she didn’t
know.” (Female, 55 years) Another participant did not
find the process of needs assessment helpful because
they had visited the centre many times in the last
seven years, commenting “we’re pretty well used to it”,
but further remarked “these sort of questions would have
been more helpful in the beginning” (Male, 75 years).
Format and language
Most participants found the tool very easy to understand
and all liked the format of being asked the questions by
health professional staff. No participants directly re-
ported problems of comprehension.
Ideal timing and frequency of SCNAT-IP screening
This sample included patients at all stages of the treat-
ment continuum, from diagnosis to follow-up care. Most
participants reported being satisfied with the timing of the
questionnaire, although several said it would have been
more useful if completed earlier in their cancer journey.
“To be perfectly honest it would have been helpful
while I was having treatment done. It’s a little bit late
because my last appointment was today.”
(Male, 35 years)
Another participant at the beginning of her treatment
for breast cancer said the questionnaire should be
completed closer to the time of diagnosis, whilst
another remarked these questions should be asked
early so they have “some information about it, [and
are] not left in the dark.”
(Female, 41 years)
However, a newly-diagnosed male participant sug-
gested that SCNAT-IP assessment should not occur too
soon after diagnosis because some subjects were “a bit
touchy” because they were still coming to terms with the
shock of their very recent cancer diagnosis.
Although most patients favoured early administration,
there were diverse views about the ideal frequency, ran-
ging from “once a week” or “every time I go in [to the
cancer centre]” to “every six months” or “every [cancer
treatment] stage”. The majority of participants believed
the SCNAT-IP assessment should be repeated through-
out treatment.
Perceived benefits of services offered following screening
All participants with moderate to high needs (n = 21,
58 %) were offered services to help address unmet needs
and many reported experiencing benefits.
“Yes, she [social worker] gave me some information
because of some of my answers. I don’t think I would
have got that information otherwise.”
(Female, 51 years)
“I have now been referred to psychology and what I
said is, “I wish this had have happened two years ago.”
(Female, 55 years)
There was also a real sense of appreciation and trust
felt by participants of the staff asking these questions,
as one participant described, “it was good to be
asked…[even though]… I do have a lot of help from my
family” (Female, 49 years) and another commented
“…a lot of that which build up in you, you like to talk
to somebody about it, but it’s hard, hard for people
just to listen” (Female, 60 years). Another participant
from a more rural location commented “I’m not going
back there [home]…apprehensive and worried and
scared to what I usually have been….[social worker] is
going to organise all the things. So when I go back it
will all sort of follow; so there will be no stress. All I
would need to worry about is just getting well.”
(Female, 50 years)
Attitudes to universal screening
Many patients supported the idea of universal screening
for Indigenous cancer patients noting that it would edu-
cate staff about Indigenous patient needs.
“A lot of them [staff] don’t understand there is
problem like family problem, money problems.”
(Female, 47 years)
Others said it helped educate patients about what help
is available to them and what to expect during treat-
ment. Some participants believed needs screening should
be optional to promote control and self-determination.
“Give ‘em the choice, you know, ‘cause a lot of ‘em feel
like they’re already being controlled by other people in
their lives as it is and they don’t need, ‘specially in a
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place like this, they don’t need to get a view of it like
'okay here’s another government organisation that’s
gonna be telling me what to do'".
(Male, 45 years)
Some participants without current unmet needs be-
lieved needs assessment was more worthwhile for others
for altruistic reasons.
“I’m pretty articulate and pretty aware of what the
processes are within hospitals and so forth, but for
somebody else you know, I think it’s something that
needs to be done.”
(Male, 61 years)
Whilst being generally satisfied with the SCNAT-IP
and willing to complete it, some participants believed
that for other Indigenous people needs screening is im-
portant because of cultural factors such as being "shy"
and “a reluctance to talk about problems or articulate
their needs”.
Despite the SCNAT-IP being specific to Indigenous
people, several participants said that SCNAT-IP would
be relevant for all cancer patients irrespective of race.
Two participants interviewed did not support universal
screening for Indigenous people with cancer, one be-
cause she believed some questions were “too personal”
and a second said he was “not sure” why.
“They might think that you’re violating that little part
of their life that they can hold tight.”
(Female, 60 years)
Staff qualitative data
Perceived benefits of screening
Many staff said there were multiple benefits of the
SCNAT-IP, including its comprehensiveness, its system-
atic approach to needs assessment and the opportunities
for early intervention which other less formal assess-
ments methods did not offer. Using the SCNAT-IP was
also reported to help staff increase their awareness and
identification of Indigenous patients in their clinic.
“It picks up things that I think would never have come
up until we were at a real crisis point”.
(Oncology social worker)
Several staff said it helped to build rapport, made pa-
tients feel “heard”, and helped clarify patient expecta-
tions of services. Some staff reported they liked using an
Indigenous-specific questionnaire because it fostered
positive and collaborative relationships with Indigenous
patients.
“The feedback I’ve got from patients was they’ve
certainly felt like they were heard which I think is
something Aboriginal patients here have found
difficult in the past.”
(Oncology social worker)
“I think it allows people then to have a connection
with the social work team here as well. I’ve found that
people that may otherwise not have had any contact
with the social workers here have been able to make
contact in a way that has been positive.”
(Oncology social worker)
Staff also identified that using the SCNAT-IP helped edu-
cate staff members less familiar with working with Indigen-
ous clients about culturally-specific needs and services.
“I think it’s also a good opportunity for staff who may
not be as experienced or, you know, trained for working
with people of Indigenous background to have this sort
of specific tools to use. It can make some people a little
bit more comfortable being able to ask some of these
questions otherwise they may not know where to start
or the right language to use.”
(Oncology social worker)
The verbal format of the tool was seen as a distinct ad-
vantage over other written scales.
Barriers to use of the SCNAT-IP in routine care
The most commonly identified barriers to using the tool
were the time needed to arrange an appointment and to
complete the interview at the patients' pace. SCNAT-IP
interviews (including follow-up discussion of needs) lasted
between 6 and 45 min with an average duration of 23 min.
“As much as we want to sit and have a really good
yarn with people, having so many questions in it [the
questionnaire]... it probably encourages them to yarn a
lot more…I think there’s the potential to be a lot of
breaks in between the questions for yarning and you
need to allow a bit more time”.
(Cancer care coordinator)
Logistical problems were especially common for rural
or remote patients because many attend clinics
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infrequently and have long travel times to consider, and
this impacted on their ability to allow sufficient time to
conduct the assessment.
Difficulties with comprehension of the tool were only
reported at one site where many patients spoke an Indi-
genous language as their primary language. Despite
health care interpreters being available upon patient or
staff request at this site, many patients preferred to con-
duct interviews in English and relied on accompanying
family members and/or staff to assist with translation.
Some staff reported that some patients had difficulty
distinguishing between lower levels of need (e.g. ‘a little
more’ versus ‘some more’ help), hence requiring further
clarification by staff. Rapport building and allowing plenty
of time to complete the interview were reported as having
helped to reduce comprehension difficulties. Several staff
also reported that some questions were not relevant to pa-
tients because of the time frame (i.e. ‘in the past month’)
because of different patients’ stages in the treatment tra-
jectory (e.g. hospital items for newly-diagnosed patients).
Whilst one staff member identified a cultural tendency
for Indigenous people to be private or reluctant to dis-
close personal information as a potential barrier to using
the SCNAT-IP, another staff member saw the structured
and direct nature of the tool as a benefit in this respect.
"Often in my experience Indigenous people are quite
private and they’ll say things are fine or they don’t
need any help but it’s good actually having those
questions as prompts."
(Cancer care coordinator)
Impact on workload
The majority of staff said that completing the questionnaire
took additional time but there were concomitant time sav-
ings because they had a better understanding of patient
needs and could therefore provide early intervention.
“I think it definitely makes up for it later on because
you can activate services a bit earlier.”
(Oncology social worker)
Some staff reported it reduced their workload. Others
said it increased workload but this was sometimes ap-
praised in a positive way.
“I mean it’s… it’s increased my workload but that’s ok, I
see that as fine. It’s increased my workload but that’s good
practice. It’s part of doing a thorough assessment with
people with cancer and being aware of unmet needs.”
(Oncology social worker)
Experience using screening tools was reported to re-
duce the time required. One staff member believed the
impact on workload would be less if the questionnaire
were conducted at the time of initial service entry when
other questionnaire information is routinely gathered.
Team communication
Several benefits to team communication were reported
by staff including improved communication with IHWs,
and nursing and medical staff.
“It’s probably given me the confidence to liaise more
with our Aboriginal liaison officers which I haven’t
done in the past very much.”
(Cancer care coordinator)
One staff member said that using the SCNAT-IP iden-
tified gaps in patients’ understanding of their diagnosis
or treatment. This staff member reported that the
SCNAT-IP:
“helps the doctors here understand how they need to
change the way they explain things to their Indigenous
patients”.
(Oncology social worker)
Making SCNAT-IP results available to nursing and
medical staff in patient files was reported to facilitate
better communication about patients’ psychosocial needs.
One staff member believed there were greater opportun-
ities for the SCNAT-IP to have a positive impact on team
communication if it were used early in the treatment
trajectory.
Impact on referral pathways
Many staff reported that using the SCNAT-IP triggered
new supportive care referrals. One clinician from a
metropolitan hospital, who interviewed a number of pa-
tients from regional areas, observed that completing the
SCNAT-IP increased her awareness of her need to better
understand referral networks in regional areas. However,
staff based in regional clinics observed little or no im-
pact on referral pathways. This was attributed to the
relatively small numbers of Indigenous patients who
were assessed in those clinics and the fact that most of
their patients were not newly-diagnosed and were
already linked to local support services.
Suggested changes
Several staff members suggested minor changes to the
structure, wording or format of the SCNAT-IP tool in-
cluding reducing the number of items, further simplifying
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the wording and modifying the response time frame (i.e.
‘in the past month’) to make it more applicable across the
whole treatment continuum. It was also suggested to
group items by domain and use domain headings to help
clarify item content, as well as revise the preamble to clar-
ify the purpose and response format (i.e. use of emoti-
cons), and highlight the fact that some items were not
relevant to all patients. More advice for staff members
about the time required to complete the instrument and
follow-up discussion about needs was also recommended.
Contradictory views about who should complete the as-
sessment were noted, with one staff member suggesting
wider use, for example, by treating doctors or ward nurs-
ing staff, and another expressing reservations as to
whether the medical or ward staff would be the best team
members to assess and respond to unmet needs.
Discussion
Overall patient acceptability of the SCNAT-IP was high,
with the majority of participants finding the tool easy to
understand. They liked the format and appreciated being
asked by health professionals about their supportive care
needs. These results are consistent with the results of a
quantitative analysis of acceptability and feasibility in
this sample [33]. They also align with the results of pa-
tient and key informant interviews conducted during the
development of the SCNAT-IP [31] and with past re-
search that demonstrated the acceptability of the unmet
needs assessment screening amongst the general Austra-
lian cancer population [30]. Both patients and staff in
this study believed SCNAT-IP assessment would be most
useful early on in the treatment trajectory, with reassess-
ment throughout treatment tailored to individual need.
Indigenous patients' cultural disconnection within the
healthcare system is well documented [11, 24, 36] and
the favourable results regarding the patient acceptability
of the SCNAT-IP may simply have been due to health
professionals taking more time to sit and talk with pa-
tients. However, our results indicate that it was more
than this. Patients liked being asked about their support-
ive care needs in a structured manner and they reported
the process was very helpful because this had not oc-
curred prior to the implementation of the SCNAT-IP.
The SCNAT-IP also provided health professionals with
the means to have these discussions in a culturally ap-
propriate format and they further commented that the
tool picks up things they would not have identified if
they were simply taking the time to sit and talk with the
patient.
Basic infrastructure and logistical issues, such as lack
of transport and suitable accommodation, are also re-
ported to impede Indigenous Australians’ access to can-
cer care and treatment services [11, 15, 23, 37]. The use
of the SCNAT-IP is intended to assist health professionals
to identify and subsequently address these important prac-
tical and logistical issues to improve access and uptake of
cancer care.
Whilst this study provides additional evidence for the
feasibility and acceptability of the SCNAT-IP, some staff
identified comprehension difficulties amongst patients
with low English literacy as a potential barrier. However,
patients who spoke Indigenous languages at home did
not report any comprehension difficulties [33]. Reasons
for this discrepancy are not clear. Although in most
parts of Australia less than 10 % of the Indigenous popu-
lation speak an Indigenous language at home (in the NT
this figure rises to over 60 %) [38], language and literacy
are commonly reported to be barriers to accessing
health care and support services [24, 28]. These barriers
may be due to Indigenous patients’ lack of cancer know-
ledge and confidence in communicating with health pro-
fessionals or navigating the health system, as well as
cancer care professionals not tailoring their language to
ensure that Indigenous patients fully comprehend their
diagnoses, prognoses and treatment options [16, 39].
Given the verbal nature of the SCNAT-IP and the fact
that most clinicians are non-Indigenous, health care in-
terpreters are a preferred delivery method. Despite
trained health care interpreters being available in this
study they were under-utilised. Using family members as
interpreters is not recommended practice when health
communication is of a complex or sensitive nature be-
cause it can lead to serious misunderstandings [40]. Our
study did not formally assess participants’ need for an
interpreter or specifically explore the relationship be-
tween language spoken at home and time required to
complete the instrument. Future studies should consider
using more formal methods of assessing need for an in-
terpreter and/or consider mandating use of trained
health care interpreters for participants who primarily
use Indigenous languages.
This trial included sites servicing Indigenous people
living in metropolitan and regional areas, as well as
those from remote communities. Our study did not as-
sess geographical variations because participants residing
in remote and metropolitan areas were under-
represented in the sample. However, participants were
recruited from four diverse cancer services which repre-
sented a range of geographical locations, service models
and Indigenous communities. Our aggregated study data
suggests that the SCNAT-IP is acceptable and feasible for
use in a variety of service settings. Given the small number
of participants from remote and very remote communities
in this study, this finding should be interpreted with cau-
tion and further research involving those from remote and
very remote communities is required. A number of Indi-
genous people were excluded from this study due to indi-
vidual and system related issues such as patients not
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turning up for appointments, competing priorities, incor-
rect Indigenous status recorded on patient medical re-
cords, difficulties scheduling appointments and travel
issues. These issues may represent unmet needs beyond
the scope of this study and the SCNAT-IP, and could also
be important in improving Indigenous patients’ health
outcomes. These individual and systemic issues affect In-
digenous health more generally, but none-the-less impact
on the delivery of cancer care and potentially the health
outcomes of Indigenous Australians.
Although conducted in Australia and involving Indi-
genous Australians exclusively, this is the first qualitative
study to explore feasibility and acceptability of an
Indigenous-specific psychosocial screening tool. Further
research is needed to explore the validity and possible
adaption of the SCNAT-IP for other Indigenous groups.
An interesting and somewhat unexpected finding of
this study was the inter-cultural benefits of the SCNAT-
IP, with a positive and bi-directional exchange of infor-
mation and cultural knowledge reported, potentially
leading to improved inter-cultural collaboration and re-
lationships that come from using a culture-specific tool
like the SCNAT-IP. Whilst not the focus of this study,
future studies should consider expanding study out-
comes to include broader cultural benefits in addition to
the more traditional service delivery outcomes and pa-
tient self-report measures which have formed the focus
of many previous screening trials.
In considering the findings of this study some limita-
tions should be acknowledged. First, although the study
aimed to recruit all eligible Indigenous cancer patients
seen during the study period, more than half of all po-
tentially eligible Indigenous cancer patients were not in-
vited to participate in this study for the reasons outlined
above. Second, a small number of patients identified in
medical records as being Indigenous did not self-identify
as Indigenous when invited to the study. Third, inaccur-
acy of medical records to identify cancer patients of
Aboriginal and Torres Strait Islander background may
have influenced the results. Fourth, although the major-
ity of participants had high levels of English fluency and
did not require interpreters, it is likely that the routine
use of interpreters amongst those who spoke Indigenous
language(s) as their primary language would have in-
creased the range and richness of responses for those
patients. Fifth, the early onset of the wet season in the
NT impeded patient transport from remote communi-
ties to the clinic, which reduced overall patient numbers
during this trial. As a result we may have missed the
views of those most marginalised and hardest to reach
due to distance and other barriers not mentioned (cost,
competing priorities). Finally, although the study
intentionally included participants from a range of geo-
graphic areas, we acknowledge that further research is
needed with larger numbers of participants from remote
and metropolitan areas to ensure the generalisability of
the findings. Despite these potential biases which may im-
pact on validity, this study had a high recruitment rate
and a relatively large sample size for qualitative studies.
This study confirmed the SCNAT-IP is applicable to
both the research and clinical cancer care settings. For
clinical purposes, our findings suggest that the SCNAT-IP
should be used at a point early in the treatment trajectory
with reassessment at subsequent time points dependent
on individual patient need. Overall, the SCNAT-IP will
greatly assist cancer care providers to identify Indigen-
ous cancer patients’ unmet needs and priorities for ac-
tion. Further, it will also assist cancer care providers to
assess the adequacy of their services in addressing
patients’ needs and identify areas for service improve-
ment. Additional benefits include enhancing patient-
provider communication and improving patients’ ex-
perience and satisfaction with cancer care. Ultimately
the goal is to bring about positive changes to patient
management and improve cancer outcomes for Indi-
genous Australians.
Conclusions
This study provides further evidence for the feasibility
and acceptability of the SCNAT-IP and its potential to
help reduce the inequalities in cancer care experienced
by Indigenous Australians. The results have led to minor
modifications to the SCNAT-IP to enhance its clarity
and suitability for use in a variety of settings. Strategies
to promote and disseminate the SCNAT-IP are currently
underway. Future studies should consider using more
formal methods of assessing need for an interpreter and/
or consider mandating use of trained health care inter-
preters for participants who primarily use Indigenous
languages.
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